Heart Failure, AF, and Mortality After RSV in Older Adults
RSV Poses Significant Cardiovascular Risks for Older Adults, New Study Reveals
Key Findings Highlight Increased Heart Failure and Mortality Rates
[City, State] – [Date] – Respiratory Syncytial Virus (RSV), frequently enough perceived as a common cold, is emerging as a significant threat too the cardiovascular health of older adults, according to groundbreaking research published in the Journal of the American Geriatrics Society. The study, led by Verschoor and colleagues, reveals that RSV infections are associated with a substantially higher incidence of cardiovascular events, including heart failure, and poorer secondary health outcomes such as increased mortality and longer hospital stays.
RSV and Cardiovascular events: A Stark Connection
the research meticulously examined hospitalization data, comparing outcomes for older adults with RSV to those with urinary tract infections (UTIs) and fractures. For individuals without pre-existing cardiovascular conditions, the risk of experiencing a cardiovascular event was alarmingly higher in patients with RSV. Specifically,the rate was 2.61 times greater than in patients with UTIs and 2.29 times greater than in those with fractures. While the study noted higher rates of stroke in RSV patients, the limited incidence of this specific event resulted in wide confidence intervals, underscoring the need for further investigation.
Secondary Outcomes: A Deeper Dive into RSV’s Impact
Beyond primary cardiovascular events, the study illuminated several critical secondary outcomes for older adults hospitalized with RSV. Patients diagnosed with RSV faced a significantly increased risk of 30-day mortality, higher rates of intensive care unit (ICU) admission, and prolonged hospital stays compared to their counterparts with UTIs or fractures.
The odds of ICU transfer were notably elevated for RSV patients, irrespective of their prior cardiovascular history.When compared to patients with UTIs or fractures who had no pre-existing cardiovascular conditions, the likelihood of ICU admission was substantially higher. The odds ratio (OR) for ICU admission was 4.63 (95% CI, 3.26-6.58) for those with RSV compared to UTI patients, and 3.75 (95% CI, 2.60-5.42) compared to fracture patients.
Moreover, 30-day mortality rates were generally elevated among RSV patients, with figures ranging from 1.49 to 3.98 times higher than in comparison groups. Hospital stays were also extended, with RSV patients experiencing lengths of stay approximately 11% to 32% longer, with the exception of fracture cases where stays were shorter regardless of cardiovascular status.
The risk of 30-day readmission also showed a concerning trend. Patients with RSV had a higher risk of readmission than those with fractures (OR, 1.36; 95% CI, 1.08-1.71), though it was lower than for those with UTIs (OR, 0.73; 95% CI, 0.59-0.90).
Expert Recommendations: vigilance and proactive Care
“Our findings further substantiate the importance of RSV as a significant cause of short- and long-term health outcomes in older adults, and in particular, the rate of heart failure,” stated Verschoor and colleagues in their concluding remarks. They emphasized that while the variable nature of RSV testing over the past two decades limits the generalizability of findings to all older patients hospitalized for RSV,the implications are clear.
The researchers strongly advocate for increased in-hospital monitoring and routine follow-up for older adults diagnosed with RSV. this proactive approach should focus on identifying cardiovascular symptoms indicative of decompensation, such as shortness of breath, arrhythmias, and weight gain. Such vigilance, they suggest, might potentially be beneficial in mitigating long-term adverse outcomes.
The Economic and Public Health Imperative
Even though RSV infections are less prevalent than influenza in older adults, the study highlights that they represent a considerable economic burden on healthcare systems. The findings underscore the critical need for robust and effective public health strategies, including the promotion and uptake of RSV vaccines, to protect this vulnerable population.
References:
- Verschoor CP, Cerasuolo JO, Caswell JM, et al. Respiratory Syncytial Virus (RSV)‐Related hospitalization and increased Rate of Cardiovascular Events in Older Adults. J Am Ger Soc. Published online July 23, 2025. doi: 10.1111/jgs.19591
- How does infection with respiratory syncytial virus